⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Jabil Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Jabil Inc.
↗St. Petersburg, Florida, USA
Jabil Inc. is a global manufacturing solutions provider that offers comprehensive engineering, manufacturing, and supply chain services. The company serves a diverse range of industries, including healthcare, automotive, cloud data centers, and renewable energy, helping brands bring products from initial design to commercial scale.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:CDMO
Sub-Industry:Electronics Manufacturing Services / Pharmaceutical Solutions
SIZE & FINANCIALS
Employees:10000+
Revenue:$29.8B (FY25)
Founded:1966
Ownership:public
Status:operating
STOCK
Exchange:NYSE
Ticker:JBL
Market Cap:$38.4B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Manufacturing/CDMO service provider)
Modalities:Aseptic fill/finish, Oral solid dose, Drug-device combination products
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Pharmaceutics International, Inc. (Pii)
Key Partnerships:Kymanox Corporation (Regulatory and life sciences services)
COMPETITION
Position:Leader
Competitors:Celestica, Flex, Foxconn, Sanmina, Plexus
LEADERSHIP
Key Executives:
Mike Dastoor - CEO
Mark Mondello - Chairman
LINKS
Website:jabil.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Jabil Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.